You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Zanubrutinib Pill
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Dec 6, 2022

ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • (no location specified)
    May 7, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Nanjing (JWCAR029 (Relmacabtagene Autoleucel))

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • JWCAR029 (Relmacabtagene Autoleucel)
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Feb 17, 2022

    Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

    Not yet recruiting
    • Lymphoproliferative Disorders
    • +3 more
    • No intervention
    • (no location specified)
    Jan 30, 2023

    Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Whittier, California
      Innovative Clinical Research Institute
    Aug 8, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
      • (no location specified)
      Apr 5, 2022

      National Acalabrutinib Observational Study

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Non interventional study
      • (no location specified)
      Jun 27, 2022

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

      Not yet recruiting
      • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
        • (no location specified)
        Dec 16, 2022

        Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • [U-13C]glucose
        • [13C5]glutamine
        • Madison, Wisconsin
          University of Wisconsin
        Jun 15, 2022

        Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

        Completed
        • CLL
          • Tampere, Finland
            Tampere university Hospital
          Feb 22, 2022

          Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

          Terminated
          Has Results
          • Small Lymphocytic Leukemia (SLL)
          • Chronic Lymphocytic Leukemia (CLL)
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 15, 2022

          B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

          Not yet recruiting
          • B-cell Malignancy
          • +7 more
          • (no location specified)
          Oct 26, 2022

          Financial Difficulty in Patients With Blood Cancer

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Multiple Myeloma
            • Chapel Hill, North Carolina
              UNC Medical Center
            Aug 9, 2022

            Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

            Recruiting
            • Chronic Lymphocytic Leukemia
            • +4 more
            • Tampa, Florida
              Moffitt Cancer Center
            Jan 12, 2023

            Venetoclax in Patients With Chronic Lymphocytic Leukemia

            Recruiting
            • Chronic Lymphocytic Leukemia
            • Taipei, Taiwan
              National Taiwan University Hospital
            Oct 27, 2021

            Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

            Recruiting
            • Chronic Lymphocytic Leukemia
            • Mantle Cell Lymphoma
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Aug 22, 2022

            Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

            Not yet recruiting
            • Autoimmune Hemolytic Anemia
            • +3 more
            • Ibrutinib 420 mg
            • (no location specified)
            Jan 12, 2023

            Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

            Recruiting
            • Hypogammaglobulinemia
            • +2 more
            • Columbus, Ohio
            • +1 more
            Jan 16, 2023

            CLL, Leukemia Trial in Houston (Eltrombopag)

            Completed
            • CLL
            • Leukemia
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            Mar 14, 2022

            Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)

            Active, not recruiting
            • Chronic Lymphocytic Leukemia
            • Questionnaire Administration
            • Ruxolitinib Phosphate
            • Houston, Texas
              M D Anderson Cancer Center
            Feb 2, 2022

            Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

            Active, not recruiting
            • Chronic Lymphocytic Leukemia
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            Feb 23, 2022

            Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

            Recruiting
            • Chronic Lymphocytic Leukemia
            • +4 more
              • Bobigny, France
              • +8 more
              Mar 23, 2022

              Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

              Active, not recruiting
              • Chronic Lymphocytic Leukemia
              • +5 more
              • Houston, Texas
                M D Anderson Cancer Center
              Mar 15, 2022

              Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)

              Recruiting
              • Chronic Lymphoid Leukemia in Relapse
              • Belimumab 200 MG/ML [Benlysta]
              • standard of care
              • Tuebingen, BW, Germany
                University Hospital Tuebingen, CCU Translational Immunology
              Feb 2, 2022